119 related articles for article (PubMed ID: 32853658)
1. Inhibition of neuronal Na
Peng YS; Wu HT; Lai YC; Chen JL; Yang YC; Kuo CC
Neuropharmacology; 2020 Nov; 179():108266. PubMed ID: 32853658
[TBL] [Abstract][Full Text] [Related]
2. Characterization of lamotrigine inhibition of Na+ channels in rat hippocampal neurones.
Kuo CC; Lu L
Br J Pharmacol; 1997 Jul; 121(6):1231-8. PubMed ID: 9249262
[TBL] [Abstract][Full Text] [Related]
3. Selective stabilization of the intermediate inactivated Na
Lin YC; Lai YC; Lin TH; Yang YC; Kuo CC
Biochem Pharmacol; 2022 Mar; 197():114928. PubMed ID: 35063442
[TBL] [Abstract][Full Text] [Related]
4. V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels.
Ilyin VI; Hodges DD; Whittemore ER; Carter RB; Cai SX; Woodward RM
Br J Pharmacol; 2005 Mar; 144(6):801-12. PubMed ID: 15778702
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation.
Niespodziany I; Leclère N; Vandenplas C; Foerch P; Wolff C
J Neurosci Res; 2013 Mar; 91(3):436-43. PubMed ID: 23239147
[TBL] [Abstract][Full Text] [Related]
6. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine.
Sheets PL; Heers C; Stoehr T; Cummins TR
J Pharmacol Exp Ther; 2008 Jul; 326(1):89-99. PubMed ID: 18378801
[TBL] [Abstract][Full Text] [Related]
7. Slow binding of phenytoin to inactivated sodium channels in rat hippocampal neurons.
Kuo CC; Bean BP
Mol Pharmacol; 1994 Oct; 46(4):716-25. PubMed ID: 7969051
[TBL] [Abstract][Full Text] [Related]
8. Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States.
Jo S; Bean BP
Mol Pharmacol; 2017 Apr; 91(4):277-286. PubMed ID: 28119481
[TBL] [Abstract][Full Text] [Related]
9. Activity of the anticonvulsant lacosamide in experimental and human epilepsy via selective effects on slow Na
Holtkamp D; Opitz T; Niespodziany I; Wolff C; Beck H
Epilepsia; 2017 Jan; 58(1):27-41. PubMed ID: 27864845
[TBL] [Abstract][Full Text] [Related]
10. Discovery of lacosamide affinity bait agents that exhibit potent voltage-gated sodium channel blocking properties.
Park KD; Yang XF; Lee H; Dustrude ET; Wang Y; Khanna R; Kohn H
ACS Chem Neurosci; 2013 Mar; 4(3):463-74. PubMed ID: 23509982
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones.
Xie X; Lancaster B; Peakman T; Garthwaite J
Pflugers Arch; 1995 Jul; 430(3):437-46. PubMed ID: 7491269
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of lidocaine inhibition by open-channel blockers that generate resurgent Na current.
Bant JS; Aman TK; Raman IM
J Neurosci; 2013 Mar; 33(11):4976-87. PubMed ID: 23486968
[TBL] [Abstract][Full Text] [Related]
13. The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.
Errington AC; Stöhr T; Heers C; Lees G
Mol Pharmacol; 2008 Jan; 73(1):157-69. PubMed ID: 17940193
[TBL] [Abstract][Full Text] [Related]
14. Ranolazine reduces neuronal excitability by interacting with inactivated states of brain sodium channels.
Kahlig KM; Hirakawa R; Liu L; George AL; Belardinelli L; Rajamani S
Mol Pharmacol; 2014 Jan; 85(1):162-74. PubMed ID: 24202911
[TBL] [Abstract][Full Text] [Related]
15. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: a comparison with carbamazepine, oxcarbazepine and lacosamide.
Hebeisen S; Pires N; Loureiro AI; Bonifácio MJ; Palma N; Whyment A; Spanswick D; Soares-da-Silva P
Neuropharmacology; 2015 Feb; 89():122-35. PubMed ID: 25242737
[TBL] [Abstract][Full Text] [Related]
16. Block of human cardiac sodium channels by lacosamide: evidence for slow drug binding along the activation pathway.
Wang GK; Wang SY
Mol Pharmacol; 2014 May; 85(5):692-702. PubMed ID: 24563546
[TBL] [Abstract][Full Text] [Related]
17. Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders.
Curia G; Biagini G; Perucca E; Avoli M
CNS Drugs; 2009; 23(7):555-68. PubMed ID: 19552484
[TBL] [Abstract][Full Text] [Related]
18. Functional consequences of lidocaine binding to slow-inactivated sodium channels.
Balser JR; Nuss HB; Romashko DN; Marban E; Tomaselli GF
J Gen Physiol; 1996 May; 107(5):643-58. PubMed ID: 8740377
[TBL] [Abstract][Full Text] [Related]
19. A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal Na+ channels.
Kuo CC
Mol Pharmacol; 1998 Oct; 54(4):712-21. PubMed ID: 9765515
[TBL] [Abstract][Full Text] [Related]
20. How Can an Na
Lin YC; Lai YC; Chou P; Hsueh SW; Lin TH; Huang CS; Wang RW; Yang YC; Kuo CC
Ann Neurol; 2021 Jun; 89(6):1099-1113. PubMed ID: 33745195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
